Home chemotherapy for lung cancer: A five year retrospective study;Chimiothérapie à domicile du cancer bronchique. Etude rétrospective sur cinq ans

Revue des Maladies Respiratoires

Volumn 20, Issue 5 I, 2003, Pages 683-689

  Virally, J ^a   Fouques Duparc, V ^b   Lazzerini, C ^c   Boiron, C ^a   Jagot, J L ^a   Mathieu, M ^a  

^a Centre Hospitalier Robert Ballanger CHRB   (France)

^b Direction des Affaires Sanitaires et Sociales de Paris   (France)

^c NONE

Author keywords

Bronchial Carcinoma; Chemotherapy; Home care Services; Outpatient; Quality of Life

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; GEMCITABINE; NAVELBINE;

ADULT; AGED; ARTICLE; FEMALE; GENERAL PRACTITIONER; HOME CARE; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; RETROSPECTIVE STUDY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; FEMALE; HOSPITAL BED CAPACITY; HUMANS; LUNG NEOPLASMS; MALE; MEDICATION ERRORS; MIDDLE AGED; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SAFETY; TREATMENT OUTCOME; VINBLASTINE;

EID: 0242624485     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rezvani A, Doyon F: Tendances récentes de la mortalité par cancers bronchiques en France. Bull Cancer 1996; 83: 910-4.
2. Souquet PJ, Chauvin F, Boissel JP, Cellerino R, Cormier Y, Ganz PA, Kaasa S, Pater JL, Quoix E, Rapp E: Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet 1993; 342: 19-21.
3. Marino P, Preatoni A, Cantoni A: Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb non small cell lung cancer. A meta-analysis. Cancer 1995; 76: 593-601.
4. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. Bmj 1995; 311: 899-909.
5. Depierre A, Milleron B, Moro-Sibilot D, Chevret S, Quoix E, Lebeau B, Braun D, Breton JL, Lemarie E, Gouva S, Paillot N, Brechot JM, Janicot H, Lebas FX, Terrioux P, Clavier J, Foucher P, Monchatre M, Coetmeur D, Level MC, Leclerc P, Blanchon F, Rodier JM, Thiberville L, Villeneuve A, Westeel V, Chastang C: French Thoracic Cooperative Group. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage 1 (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 2002; 20: 247-53.
6. Loi n° 2002-303 du 4 mars 2002 relative aux droits des malades et à la qualité du système de santé.
7. Le Chevalier T, Brisgand D, Douillard JY, Pujol JL, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol 1994; 12: 360-7.
8. The Elderly Lung Cancer Vinorelbine Italian Study Group Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer. J Natl Cancer Inst 1999; 91: 66-72.
9. Anderson H, Lund B, Bach F, Thatchet N, Walling J, Hansen HH: Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study. J Clin Oncol 1994; 12: 1821-6.
10. Abtatt RP, Bezwoda WR, Goedhals L, Hacking DJ: Weekly gemcita- bine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol 1997; 15: 744-9.
11. Circulaire ministérietle du 30 mai 2000 relative à l'HAD.
12. Ferri-Dessens RM, Thomas P, Barlesi F, Raholimina V, Kleisbauer JP: Les modes d'hospitalisation nécessaires pour une prise en charge de qualité en oncologie thoracique. Rev Mal Respir 2001; 18: 35-9.
13. King MT, Hall J, Caleo S, Gurney HP, Harnett PR: Home or hospital? An evaluation of the costs, preferences, and outcomes of domiciliary chemotherapy. Int J Health Serv 2000; 30: 557-79.
14. Rischin D, White MA, Matthews JP, Toner GC, Watty K, Sulkowski AJ, Clarke JL, Buchanan L: A randomised crossover trial of chemotherapy in the home: patient preferences and cost analysis. Med J Aust 2000; 173: 125-7.
15. Borras JM, Sanchez-Hernandez A, Navarro M, Martinez M, Mendez E: Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomised controlled trial. BMJ 2001; 322: 826.
16. Pujol JL, Beaupin C, Quantin X, Savelli K, Odoul M, Godard P: Une ordonnance de chimiothérapie protocolaire pour améliorer la sécurité de prescription en cancérologie thoracique. Rev Mal Respir 1999; 16: 107-9.
17. Foucher P, Michaux K, Fanton A, Rossignoli N, Alabeatrice C, Bricout M, Camus P: Cancer bronchique et chimiothérapie à domicile: expérience d'un service de pneumologie. Rev Mal Respir 2000; 17: S43.
18. Blanchon B, Berkou N, Charvier M, Dupont-Zacot E, Parmentier M: Prise en charge des cancers bronchiques en le Ile-de-France. Rev Mal Respir 2000; 17: 839-846.
19. Lowenthal RM, Piaszczyk A, Arthur GE, O'malley S: Home chemotherapy for cancer patients: cost analysis and safety. Med J Aust 1996; 165: 184-7.
20. Thomas P, Raholimina V, Ferri-Dessens RM, Pibarot M, Penot Ragon C, Gregoire R, Kleisbauer JP: Insuffisance de la valorisation PMSI de la chimiothérapie ambulatoire en oncologie pulmonaire. Rev Mal Respir 2000; 17: 659-63.